Richard Thomas

Richard serves as a director for Genstar portfolio companies Signant Health and Advarra. Independently he is a director for Trialbee in Malmo, Sweden and serves as an advisory board member for technology companies Change Healthcare (NASDAQ: CHNG), Datavant, Vitaltrax and Lokavant. As CEO of R Ventures Inc, Richard is also an active investor and advisor to early stage technology companies.

Prior to Genstar, Richard served as President-Technology & Solutions and executive committee member at Quintiles, the world’s largest pharma services organization, from 2005-2016. He built its technology business through a high growth era which included a successful IPO in 2013 (NYSE: Q), and merger with IMS Health in 2016 to create IQVIA (NYSE: IQVIA). He led the creation of its award-winning technology business providing platforms used by many of the world’s leading pharmaceutical companies for clinical development, commercialization and real-world evidence research.

Richard has a 30-year track record of leadership and innovation building technology and data/analytics focused product and services businesses across industries including roles at Nielsen, Castrol and bay area startup Telephia. He has received multiple accolades for innovation including the #1 business technology innovator across the pharmaceutical industry (2011, 2012), and the Scrip award for best clinical development technology innovation (2013).

Richard also competes globally in motorsport with numerous podiums and two North America championships.